Printer Friendly

Affordable drugs needed for diseases of poverty, says WHO.

The World Health Organization has called for greater cooperation between governments, drug companies and other stakeholders to provide a mechanism for creating new medicines and products for treating diseases of poverty affecting developing countries. Medicines must be affordable and accessible. Neglected or tropical diseases contribute to over 50% of the disease burden in low-income countries, yet between 1975 and 1999, only 13 of 1,400 new drugs were developed for these diseases. A global strategy and action plan will be presented to the World Health Assembly in May 2008 for endorsement.

(1.) Affordable drugs for so-called diseases of poverty. PROCAARE Healthnet, 13 September 2007.
COPYRIGHT 2008 Reproductive Health Matters
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:ROUND UP: Service Delivery
Publication:Reproductive Health Matters
Article Type:Brief article
Geographic Code:4EUUK
Date:May 1, 2008
Previous Article:Microbicide found not to reduce HIV risk, South Africa.
Next Article:Strategies used by Bolivian women in patient-led partner notification for syphilis.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters